Evaluation of human induced pluripotent stem cell (hiPSC)-derived tri-culture as in ...
Bioreactor-Generated hiPSC Cardiomyocytes for Engineered Heart Tissue Models Poster
Advancing Drug Discovery and Toxicology with Human iPSC-Derived 3D Cardiac and Brain ...
A Translational in-vitro screening platform using Non-Human PrimateiPSC-derived ...
Building manufacturing processes for reproducible, multi-year iPSC-based drug ...
Predictive In Vitro Safety Profiling of ADCs Using a Fully iPSC-Derived Human ...
A Translational in-vitro platform of Non-Human Primate iPSC-derived ventricular ...
Human iPSC-Derived Cardiomyocyte Disease Modeling of Friedreich’s Ataxia and ...
A human iPSC-based platform to screen therapeutics for ALS usingspecific and robust ...
Evaluating the Transduction Efficiency of Different AAV Serotypes onHuman ...
Ncyte® Heart in a Box™: Scalable 3D Human Cardiac Models for Drug Discovery
Building AAV Screening Workflows That Translate to GMP
.png)
Integrating iPSC-Derived Functional Models with Immunogenicity Assessment to De-Risk ...
.png)
Built for Discovery: Robust Screening Solutions Across Human iPSC-Derived Models
.png)
Designing cardiac assays for multi-year discovery and safety pipelines
Beyond binding – iPSC-based functional safety screening for oncology modalities
Advancing Gene Therapy Potency Testing with iPSC-Based Systems
Revolutionizing Cardiac Safety Assessment with NHP Cardiomyocytes
A Reduction in Animal Testing Stems From Ncardia
See How Ncardia Is Supporting the Shift From Animal Models With iPSC Technology
-1.png)
Press release: Ncardia and Cellistic appoint Jason Conner as new CEO
Industry Insights: Early Safety and Human-Relevant Models Gain Strategic Weight
Ncardia and LUMC Develop Automated Human Cardiac Microtissue Platform
Scaling Human Biology: Mariana Argenziano's Impact on iPSC Manufacturing
.svg)
Human-Relevant Discovery Begins With the Model: A Conversation With Shushant Jain
.png)
Building Human-Relevant Immuno Oncology Models: A Conversation With Ncardia’s Sanne ...
Driving Predictive Science Forward: Inside the Shift Toward Human-Relevant Drug ...
Press release: Ncardia Launches First-of-Its-Kind iPSC-Derived Non-Human Primate ...
The FDA Is Moving Past Animal Testing. Here’s How Ncardia Helps Make It Happen
Press release: Ncardia launches Ncyte® Microglia